Epassi Group Expands into Southern Europe with the Acquisition of VIP District
17.6.2025 09:00:00 EEST | Business Wire | Press release
Epassi Group’s acquisition of VIP District (www.vipdistrict.com) marks a major milestone in Epassi’s pan-European growth strategy and follows Epassi’s recent acquisition of Zest in the UK, which expanded the Group’s UK footprint and enhanced its overall employee benefits software offering. With VIP District now part of the Epassi family, the Group significantly expands its footprint into Spain and Portugal, while strengthening its existing presence in Italy, Germany, and the Netherlands.
Founded in 2010, VIP District supports over 3,000 companies with its digital platform, offering exclusive employee rewards and incentives, recognition tools, and engagement solutions. The company has become a leader in Southern Europe, helping employers boost retention, satisfaction, and wellbeing.
“This partnership accelerates our ambition to build the leading European tech platform for employee benefits and wellbeing,” said Pekka Rantala, CEO of Epassi Group. “VIP District brings a strong market position, an excellent team, and a shared passion for innovation and employee experience. Together, we are strengthening our reward services proposition across Europe, delivering even more value to our clients and their employees.”
The combination unites two highly complementary platforms – Epassi’s multi-benefit platform and VIP District’s engagement and reward services – creating a unique, scalable offering that enables employers to engage, recognize, and reward their employees with greater impact and flexibility.
“VIP District has always focused on innovation and strategic, sustainable growth,” said Jesús Alonso, CEO of VIP District. “Today’s partnership with Epassi is the latest step in our mission to become the preferred all in one employee engagement platform with benefits, employee discounts, internal communication, recognition and rewards across Europe. By combining forces, we can deliver even more value to our customers—helping them attract, motivate, and retain talent in a dynamic market.”
This acquisition further solidifies Epassi’s position as a European leader in the employee benefits ecosystem, now serving over 45,000 employers and more than 29 million users across the Nordics, UK, Ireland, Germany, the Netherlands, Italy, Spain, Portugal, and France.
About Epassi
Founded in 2007, Epassi is a leading provider of employee benefits technology operating across Finland, Sweden, Germany, the Netherlands, Italy, the UK and Ireland. Epassi’s innovative, mobile and digital first platform serves around 46,000 employers and their more than 29 million employees, partnering with over 97,000 service providers across its benefits ecosystem.
Epassi has been recognized by the Financial Times as one of the fastest growing companies in Europe in 2022, 2023, 2024, and 2025. Epassi was ranked 32nd on “Europe’s Long-term Growth Champions 2025” list.
Epassi – Boosting everyday well-being.
About VIP District
Founded in 2010, VIP District provides digital engagement solutions that help companies enhance employee experience through rewards, recognition, internal communication and exclusive discounts. Headquartered in Madrid and offices in 8 locations, the company serves over 3,000 employers and 7 million users across Europe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250616658244/en/
Contacts
Press Contacts
Seven Consultancy: epassi@seven-consultancy.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences23.9.2026 08:00:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, will present 19 abstracts and deliver a broad scientific education program at the 2026 European Academy of Dermatology and Venereology (EADV) Congress. Through these activities, Galderma will showcase how it continues to advance its pipeline and the science of dermatology, deepening understanding of biological and quality-of-life factors, while driving innovation in targeted treatments, skin longevity and evidence-based care. “At Galderma, we recognize that advancing dermatology means not only addressing the needs of patients living with common chronic skin conditions, such as atopic dermatitis and acne, but also anticipating the trends that will shape the future of skin health. Our presence at EADV demonstrates our unique ability to achieve this, with new data spanning both established areas of unmet need and emerging fields such as skin longevity, helping drive innovation and meaningful outcomes for patients today and i
Oticon Medical Launches SmartCharger for the Ponto 5 Family23.9.2026 08:00:00 EEST | Press release
Oticon Medical today announces the launch of SmartCharger for the Ponto 5 family, introducing its first rechargeable solution for percutaneous sound processors and marking a new step in convenience and portability for bone anchored hearing system users. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922863462/en/ Oticon Medical today announces the launch of SmartCharger for the Ponto 5 family, introducing its first rechargeable solution for percutaneous sound processors and marking a new step in convenience and portability for bone anchored hearing system users. Powering the Ponto 5 family The launch of SmartCharger underlines Oticon Medical’s continued commitment to the Ponto family, which includes Ponto 5 SuperPower, the world’s most powerful abutment-level sound processor,1 and Ponto 5 Mini, the world’s smallest percutaneous sound processor.1 By bringing rechargeable convenience to the Ponto sound processors, Oticon Me
Textron Aviation Marks 500th Cessna Citation Latitude Rollout22.9.2026 17:19:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the rollout of the 500th Cessna Citation Latitude business jet from the company’s Wichita, Kansas, manufacturing facility. The production milestone highlights the continued success of the world’s best-selling midsize business jet and recognizes the employees whose craftsmanship and dedication have helped make the Citation Latitude the trusted choice for operators around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922867287/en/ Textron Aviation marks 500th Cessna Citation Latitude rollout. (Photo Credit: Textron Aviation) “The rollout of the 500th Citation Latitude is a testament to the employees who build this aircraft with dedication and pride every day,” said Eric Cardinali, senior vice president, Manufacturing. “Behind every aircraft is a team committed to delivering the quality and craftsmanship our customers expect. This milestone
OCP Announces Date of Second Quarter and First Half 2026 Earnings22.9.2026 17:00:00 EEST | Press release
OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 10:00 a.m. EDT, 2:00 p.m. Morocco (GMT) and 3:00 p.m. London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2026 results at 11:00 a.m. EDT, 3:00 p.m. Morocco (GMT) and 4:00 p.m. London time (GMT+1) on Tuesday, September 29, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release
Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom